Zacks Investment Research on MSN
AGIO's filing for mitapivat in SCD gets FDA's priority tag, stock up
Agios Pharmaceuticals AGIO announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval ...
A Prescription Drug User Fee Act target date of November 1, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug ...
Cole Schenewerk’s passion for credit card points and miles has led him around the globe. Following a career in corporate finance, he now helps others maximize the rewards they earn from their spending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results